Clinical Trial Update: Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis [Phase 2]

View source ↗

Summary

The document reports a Phase 2 study investigating the efficacy of daylight-activated photodynamic therapy for cutaneous leishmaniasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Cutaneous Leishmaniasis | Phase 2 | Status: UNKNOWN